February 24, 2020

Tetra Bio-Pharma Issues Comment on Drug Development

Tetra Bio-Pharma gave investors more details on its drug development program for a candidate after it engaged with the US...
February 3, 2020

Tetra Bio-Pharma Moves Ahead with Fast Track for CAUMZ

Tetra is now able to file for fast track designation for its cannabinoid-based drug CAUMZ, which aims to treat cancer...
January 28, 2020

Tetra Provides Update on Veterinary Ophthalmic Clinical Study

Tetra has provided an update on its clinical trial to evaluate the efficacy of its drug for eye pain in...
January 24, 2020

Cannabis Weekly Round-up: Aphria Secures C$100 Million From Mystery Investor

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
January 22, 2020

Tetra Plans 2020 Product Launch, Confirms C$10 Million Offering

Tetra told investors it is moving ahead with a plan to launch its TERPACAN products in Canadian pharmacy retail locations...
January 20, 2020

Tetra Bio-Pharma Provides Update on Commercialization Plans

Tetra provided an update on its commercialization initiatives to bring its OTC Drug Identification Number products to market in 2020.
December 26, 2019

Cannabis Forecast 2020: Firms Want Investors to Do Their Homework

As another year wraps up, INN spoke with members of the marijuana industry to get their input on what 2020...